Biogen is abandoning its lackluster Alzheimer’s disease drug, Aduhelm. The Massachusetts-based company announced Wednesday that it is pulling the medication from the market following poor sales and controversy over its approval by the Food and Drug Administration in 2021. The company says it is only doing so to…
A popular class of weight loss and diabetes drugs looks to be safer than feared, at least so far. This week, the Food and Drug Administration announced it hasn’t found compelling evidence that Wegovy, Ozempic, and other GLP-1 drugs can cause suicidal thoughts or behaviors—a concern that first emerged last year. The…
Wegovy and similar weight loss drugs may cause more side effects than currently recognized. The Food and Drug Administration is now looking into whether these new generation obesity drugs can trigger hair loss, suicide ideation, and food aspiration, based on adverse event reports linked to their use. These reports are…
Drug commercials in the U.S. are set to become more intelligible. On Monday, the Food and Drug Administration updated its regulations regarding prescription drug ads that air on TV or radio. The change will specifically mandate that a drug’s side effects and other potential dangers “must be presented in a clear,…
The results of a Phase III trial published this week could soon lead to a new era for the treatment of post-traumatic stress disorder. The study found that a combination of MDMA and psychotherapy was effective at relieving PTSD symptoms when compared to standard therapy. The nonprofit organization funding this…
The Food and Drug Administration is warning several companies, including the retail chains CVS and Walgreens, to stop selling unapproved, potentially dangerous eye drop products. The agency claims that the companies have committed a number of violations in manufacturing or marketing these products. The FDA is also…
A common ingredient in over-the-counter cold and cough medicines might not be long for this world. The Food and Drug Administration is about to decide whether oral phenylephrine should remain in OTC nasal decongestant drugs. Outside experts will deliberate the topic and offer their recommendations this week, but FDA…
UK regulators are investigating the Ozempic and Saxenda weight loss drugs over reports that patients experienced suicidal and self-harming thoughts while taking the medications. The drugs skyrocketed in popularity in the U.S. as doctors began prescribing them to people who struggled with obesity, but new reports are…
